Predictive Factors for Medullary Thyroid Cancer Aggressiveness
- Conditions
- Medullary Thyroid Cancer
- Registration Number
- NCT06292988
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Brief Summary
This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.
- Detailed Description
This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival. The predictive factors included in this study are central and lateral compartment lymph node metastases as well as distant metastasis up to 1 year postoperatively, while biochemical predictors (meaning ratios such as lymphocyte to monocyte ratio etc and CEA and calcitonin drop levels) and histological predictors (such as nuclear atypia, amyloid, immunohistochemistry, desmoplasia) are included as secondary outcomes. In this study , patients \>18 years old that underwent surgery for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection) will be enrolled.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 500
- Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection
- Age < 18 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Central lymph node metastasis Number of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively Central neck compartment lymph node metastasis
Lateral lymph node metastasis Number of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively Lateral neck compartment lymph node metastasis
Distant metastasis Number of distant Metastasis found in preoperative imaging studies or up to 1 year postoperatively Liver and lung metastasis
- Secondary Outcome Measures
Name Time Method Nuclear atypia as histological predictor of aggressiveness The pathology report is held immediately after surgery nuclear atypia
White blood cell as Biochemical predictor of aggressiveness pre and postoperative laboratory exams up to 1 year postoperatively white blood cell count
Amyloid as histological predictor of aggressiveness The pathology report is held immediately after surgery amyloid
CEA as Biochemical predictor of aggressiveness pre and postoperative laboratory exams up to 1 year postoperatively Carcinoembryonic antigen (CEA) preoperatively and up to 1 year postoperatively
Immunohistochemistry as histological predictor of aggressiveness The pathology report is held immediately after surgery immunohistochemistry
Calcitonin as Biochemical predictor of aggressiveness pre and postoperative laboratory exams up to 1 year postoperatively calcitonin levels preoperatively and up to 1 year postoperatively
CEA drop as Biochemical cure marker up to 1 year postoperatively CEA drop levels
Calcitonin drop as Biochemical cure marker up to 1 year postoperatively calcitonin drop levels
Desmoplasia as histological predictor of aggressiveness The pathology report is held immediately after surgery desmoplasia
Platelet count as Biochemical predictor of aggressiveness pre and postoperative laboratory exams up to 1 year postoperatively platelet count
Trial Locations
- Locations (46)
Oregon Health & Science University, Oregon
🇺🇸Oregon City, Oregon, United States
Department of Surgery, Saint John of God Hospital, Salzburg, Austria
🇦🇹Salzburg, Austria
Saint Luc, University Clouvain, Belgium
🇧🇪Bruxelles, Belgium
Head and Neck Surgery Department, Hospital Ana Nery, Santa Cruz do Sul, Brazil
🇧🇷Santa Cruz Do Sul, Brazil
University Clinic of Surgery, University Hospital "Lozenec"
🇧🇬Sofia, Bulgaria
Chinese University of Hong Kong
🇨🇳Hong Kong, China
Head and Neck Department Oncologos del Occidente, Universidad de Caldas, Manizales, Colombia
🇨🇴Manizales, Colombia
the University Hospital Center Sestre milosrdnice, Zagreb, Croatia, Department of Otorhinolaryngology and Head and Neck Surgery
🇭🇷Zagreb, Croatia
Head and Neck Surgery, Brest University Hospital, Brest, France
🇫🇷Brest, France
The University Hospital of Poitiers, France
🇫🇷Poitiers, France
Scroll for more (36 remaining)Oregon Health & Science University, Oregon🇺🇸Oregon City, Oregon, United States